Biodesix (BDSX) Cash from Operations (2019 - 2026)

Biodesix (BDSX) has 8 years of Cash from Operations data on file, last reported at 10168000.0 in Q1 2026.

• Quarterly Cash from Operations fell 18.21% year-over-year to 10168000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 24837000.0 (up 40.78% YoY) and the FY2025 annual result came in at 23271000.0, up 52.17% from the prior year.
• Cash from Operations retreated to 10168000.0 in Q1 2026, from 778000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 937000.0 in Q2 2023 to a low of 18571000.0 in Q2 2024.
• A 5-year average of 8819411.76 and a median of 9594000.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2024 — Cash from Operations sank 2081.96% — and 2025, when it jumped 118.99%.
• Tracing BDSX's Cash from Operations over 5 years: stood at 11948000.0 in 2022, then declined by 2.8% to 12283000.0 in 2023, then jumped by 66.65% to 4096000.0 in 2024, then jumped by 118.99% to 778000.0 in 2025, then plunged by 1406.94% to 10168000.0 in 2026.
• The last three Cash from Operations figures came in at 10168000.0 (Q1 2026), 778000.0 (Q4 2025), and 8879000.0 (Q3 2025), per Business Quant data.